Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12607000230459
Ethics application status
Not yet submitted
Date submitted
21/03/2007
Date registered
1/05/2007
Date last updated
1/05/2007
Type of registration
Retrospectively registered

Titles & IDs
Public title
Clinical Electrocochleography in Meniere's Disease: The Value of Low Frequency Stimulus Biasing
Scientific title
Comparing the change in electrocochleography results in those with Meniere's compared to controls when low frequency stimulus biasing is introduced to electrocochleography performed for the investigation of vertigo.
Universal Trial Number (UTN)
Trial acronym
Low Frequency Biasing in ECochG
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Diagnosing Meniere's disease in patients with vertigo 1761 0
Condition category
Condition code
Ear 1853 1853 0 0
Other ear disorders

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Both patients with meniere's disease and a control group will undergo electrocochloegraphy with an added component of the test being introduction of a low frequency stimulus once the usual test is complete. Electocochleography is the placing of a small wire electrode through the ear drum then sending 8kHz, 2kHz, 1kHz and 500Hz sound through the wire and recording the potentials elicited from the ear in respose to these sounds. The test takes about 30min and the extra low frequency component would last about 10 minutes extra. The low frequency component would be a 50Hz sound played at the same time as the the 8kHz, 2kHz, 1kHz and 500Hz noises mentioned as the routine electrocochleographic process and the change in potentials elicited previously recorded.
Intervention code [1] 1662 0
Diagnosis / Prognosis
Comparator / control treatment
A control group will undergo electrocochloegraphy with an added component of the test being introduction of a low frequency stimulus once the usual test is complete. The control group will be those who attend the clinic of Prof Gibson for investigation of vertigo symptoms who are diagnosed on the Meniere's Clinical Score as having no Meniere's Disease- the current accepted gold standard for the diagnosis of Meniere's disease in the living patient - post mortem examination is the only certain diagnosis currently. Controls will be those who suffer from vertigo symptoms but who are would be unlikely to have endolymphatic hydrops (as found in Meniere's disease and diagnosed on electrocochleography) based on history. They may be suffering from such conditions as postural dizziness, benign positional vertigo, or labyrithitis, which do not cause endolymphatic hydrops so these patients would be expected to have a normal electrocochleogram.
Control group
Active

Outcomes
Primary outcome [1] 2596 0
The change in Summation potential (SP) of the electrocochleograph result when the low frequency stimulus bias is introduced (from electrocochleography SP without stimulus biasing).
Timepoint [1] 2596 0
The summating potential is first measured in the response elicited to the 8kHz, 2kHz, 1kHz and 500Hz stimuli in the absence of the low frequency bias. Then the low frequency noise is made at the same time as the 8kHz, 2kHz, 1kHz and 500Hz stimuli and the SP generated is again measured for each of these frequencies. The change in the SP amplitude from before to after the introduction of the low frequency bias is then calculated.
Secondary outcome [1] 4456 0
Improvement in diagnosis of Meniere's disease when correlated with the current gold standard of clinical diagnosis.
Timepoint [1] 4456 0
The outcome is measured at the same time as the clinical interview and a direct correlation done comparing the electrocochleography results (with the added low frequency noise)with the clincial score and the basic electrocochleograph results. This is a cross sectional analysis of diagnosis compared between diagnostic tests - which included the clinical interview, which is the current gold standard. There is no secondary time point.

Eligibility
Key inclusion criteria
All patients, undergoing electrocochleography for the investigation of vertigo under the care of Prof W Gibson will be invited to participate in the trial. The control group will be those with a very low Meniere's score obtained on clinical interview but are still undergoing electrocochleography -which is the current gold standard of diagnosis.
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
Hearing loss>70dB, concurrent ear pathology, stage 1 Meniere's - though the trial may change to include them based on initial results.

Study design
Purpose of the study
Diagnosis
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
There will be 2 investigators so that clinical assessor and the clinician performing the electrocochleography are blinded of the result of the other half. The patients will be not be informed of their results on clinical interview or electrocochleography until both compenents are complete so that there is no chance of them biasing the evaluating clinicians. The 2 investigators are both clinicians, who will be involved in assessment of outcomes and administration of the electrocochleography. There will be comparison of study groups based on demographics before analysis begins to ensure homogeneity of groups plus stratification analysis based on hearing level and stage of Meniere's disease.
Phase
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
1/04/2007
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
50
Accrual to date
Final

Funding & Sponsors
Funding source category [1] 2000 0
Charities/Societies/Foundations
Name [1] 2000 0
Garnett Passe and Rodney Williams Foundation Scholarship
Country [1] 2000 0
Primary sponsor type
Individual
Name
Dr Claire Iseli
Address
Country
Secondary sponsor category [1] 1811 0
Individual
Name [1] 1811 0
Professor William Gibson
Address [1] 1811 0
Country [1] 1811 0

Ethics approval
Ethics application status
Not yet submitted
Ethics committee name [1] 3707 0
Royal Prince Alfred Hospital
Ethics committee address [1] 3707 0
Ethics committee country [1] 3707 0
Australia
Date submitted for ethics approval [1] 3707 0
Approval date [1] 3707 0
Ethics approval number [1] 3707 0
Ethics committee name [2] 3708 0
associated rooms of supervising specialist Professor W Gibson in Newtown
Ethics committee address [2] 3708 0
Ethics committee country [2] 3708 0
Australia
Date submitted for ethics approval [2] 3708 0
Approval date [2] 3708 0
Ethics approval number [2] 3708 0
Ethics committee name [3] 3709 0
associated rooms of supervising specialist Professor W Gibson in Gladesville
Ethics committee address [3] 3709 0
Ethics committee country [3] 3709 0
Australia
Date submitted for ethics approval [3] 3709 0
Approval date [3] 3709 0
Ethics approval number [3] 3709 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 27765 0
Address 27765 0
Country 27765 0
Phone 27765 0
Fax 27765 0
Email 27765 0
Contact person for public queries
Name 10851 0
Dr Claire Iseli
Address 10851 0
7/155 Missenden Rd
Newtown NSW 2041
Country 10851 0
Australia
Phone 10851 0
+61 2 95191489
Fax 10851 0
+61 2 95191454
Email 10851 0
[email protected]
Contact person for scientific queries
Name 1779 0
Dr Claire Iseli
Address 1779 0
7/155 Missenden Rd
Newtown NSW 2041
Country 1779 0
Australia
Phone 1779 0
+61 2 95191489
Fax 1779 0
+61 2 95191454
Email 1779 0
[email protected]

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.